PA8480401A1 - Un metodo para la prevencion del inicio del asma - Google Patents

Un metodo para la prevencion del inicio del asma

Info

Publication number
PA8480401A1
PA8480401A1 PA19998480401A PA8480401A PA8480401A1 PA 8480401 A1 PA8480401 A1 PA 8480401A1 PA 19998480401 A PA19998480401 A PA 19998480401A PA 8480401 A PA8480401 A PA 8480401A PA 8480401 A1 PA8480401 A1 PA 8480401A1
Authority
PA
Panama
Prior art keywords
asthma
prevention
initiation
same
cetiricina
Prior art date
Application number
PA19998480401A
Other languages
English (en)
Spanish (es)
Inventor
Luc Uylenbroeck
Longueville Marc De
Anne Wilmes
Clercq Johan De
Caenegem Henriette Van
Original Assignee
Ucb Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26792214&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PA8480401(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ucb Sa filed Critical Ucb Sa
Publication of PA8480401A1 publication Critical patent/PA8480401A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
PA19998480401A 1998-08-18 1999-08-17 Un metodo para la prevencion del inicio del asma PA8480401A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9692998P 1998-08-18 1998-08-18
US9745598P 1998-08-21 1998-08-21

Publications (1)

Publication Number Publication Date
PA8480401A1 true PA8480401A1 (es) 2000-09-29

Family

ID=26792214

Family Applications (1)

Application Number Title Priority Date Filing Date
PA19998480401A PA8480401A1 (es) 1998-08-18 1999-08-17 Un metodo para la prevencion del inicio del asma

Country Status (16)

Country Link
EP (1) EP1109557B1 (enExample)
JP (1) JP3878416B2 (enExample)
AR (1) AR020167A1 (enExample)
AT (1) ATE228366T1 (enExample)
AU (1) AU749169B2 (enExample)
CA (1) CA2340920C (enExample)
DE (1) DE69904206T2 (enExample)
ES (1) ES2188232T3 (enExample)
HN (1) HN1999000140A (enExample)
MA (1) MA26676A1 (enExample)
MY (1) MY124089A (enExample)
PA (1) PA8480401A1 (enExample)
SA (1) SA99200492B1 (enExample)
TN (1) TNSN99158A1 (enExample)
TW (1) TW581675B (enExample)
WO (1) WO2000010544A2 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002221854A1 (en) * 2000-12-15 2002-06-24 U C B, S.A. Use of cetirizine or efletirizine for preventing urticaria
WO2005077371A1 (en) * 2004-02-12 2005-08-25 Ucb Farchim Sa Use of levocetirizine for the preparation of a drug
US8263581B2 (en) 2009-07-03 2012-09-11 Jdp Therapeutics, Inc. Non-sedating antihistamine injection formulations and methods of use thereof
US8513259B2 (en) 2009-07-03 2013-08-20 Jdp Therapeutics, Inc. Non-sedating antihistamine injection formulations and methods of use thereof

Also Published As

Publication number Publication date
ES2188232T3 (es) 2003-06-16
JP2002523362A (ja) 2002-07-30
EP1109557A2 (en) 2001-06-27
TW581675B (en) 2004-04-01
ATE228366T1 (de) 2002-12-15
EP1109557B1 (en) 2002-11-27
MA26676A1 (fr) 2004-12-20
JP3878416B2 (ja) 2007-02-07
WO2000010544A3 (en) 2000-05-18
DE69904206D1 (de) 2003-01-09
CA2340920C (en) 2007-10-16
DE69904206T2 (de) 2003-07-17
HN1999000140A (es) 2001-07-31
WO2000010544A2 (en) 2000-03-02
AU749169B2 (en) 2002-06-20
CA2340920A1 (en) 2000-03-02
AR020167A1 (es) 2002-04-10
MY124089A (en) 2006-06-30
TNSN99158A1 (ar) 2005-11-10
SA99200492B1 (ar) 2006-06-04
AU5734699A (en) 2000-03-14

Similar Documents

Publication Publication Date Title
ES2181868T3 (es) Composicion farmaceutica para compuestos de piperidinoalcanol.
ES2144623T3 (es) Heterociclos diaril biciclicos como inhibidores de la ciclooxigenasa-2.
ECSP034603A (es) Combinaciones sinergicas que comprenden un inhibidor de renina para enfermedades cardiovasculares
ATE220896T1 (de) Hydrogelformulierung mit gesteuerter freisetzung
AR013742A1 (es) Metodo para el tratamiento de la hipercolesterolemia con polidialilamina no substituida
ES2165990T3 (es) Thip para el tratamiento de trastornos del sueño.
DK0738152T3 (da) Anvendelse af 2-hydroxy-5-phenylazobenzoesyrederivater som kemopræventive og kemoterapeutiske midler mod coloncancer
WO2002011764A3 (en) PHARMACEUTICAL COMPOSITIONS
GT199900015A (es) Procedimiento para tratar la insuficiencia cardiaca
GT199800101A (es) Composicion farmaceutica solida que contiene un derivado de benzofurano.
ES2184960T3 (es) Nuevas pirimidin-4-onas-(5,6)-heteroaril condensadas 2,3 disustituidas.
PA8426801A1 (es) Composiciones farmaceuticas para el tratamiento de la rinitis.
ES2160145T3 (es) Composicion farmaceutica para la administracion oral de flavonoides.
ES2176296T3 (es) Composiciones farmaceuticas que permiten la liberacion prolongada de trimetacidina despues de la administracion por via oral.
NO20014241D0 (no) C16-umettede FP-selektive prostaglandinanaloger
AR028448A1 (es) Formulaciones que contienen una droga glucocorticoide para el tratamiento de enfermedades broncopulmonares
PA8480401A1 (es) Un metodo para la prevencion del inicio del asma
ES2187030T3 (es) Una nueva sal.
GT199700116A (es) Composiciones farmaceuticas
AR002191A1 (es) Composicion farmaceutica oral de compuestos de piperidinoalcanol en forma de solucion, procedimiento para su preparacion
ECSP993097A (es) Un metodo para la prevencion del inicio del asma
ES2186153T3 (es) Sulfato de 5-alfa-pregnan-3-beta-ol-20-ona para el tratamiento de tumores y de los trastornos del snc.
ES2177103T3 (es) Terapia de combinacion para el tratamiento del sida.
ES2113549T3 (es) Metodo para inhibir la replicacion de vih empleando il-4.
AR022348A1 (es) Una composicion farmaceutica para el tratamiento de los sintomas del tracto urinario inferior